The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application for SL1009 (sodium dichloroacetate oral solution) for the treatment of pyruvate dehydrogenase complex ...
Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug ...
DCA will be used with a proprietary genetic test to treat an orphan pediatric mitochondrial disease, Pyruvate Dehydrogenase Complex Deficiency (PDCD) 1. The FDA granted Priority Review for the NDA and ...
5 天
News Medical on MSNResearchers develop T cell growth method that enhances cancer-fighting ability in melanoma ...Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.
Lactate can also be converted to lactoyl-CoA, which is involved in the lactylation of histone and non-histone proteins. HK-1, hemokinin-1; G6PD, glucose 6-phosphate dehydrogenase; PKM, glycolytic ...
Pyruvate dehydrogenase kinase 1 (PDHK1), as an inhibitor of Pyruvate dehydrogenase (PDH), promotes glycolysis, thereby reducing Treg differentiation and function. Similarly, LKB1, which inhibits the ...
Osaka Metropolitan University scientists have developed an artificial photosynthesis technology that produces precursors of biodegradable nylon from biomass-derived compounds and ammonia.
According to Cour, CNP-104 initiates tolerance to pathogenic activated pyruvate dehydrogenase complex-E2 T-cells that “drive inflammation in bile ducts, leading to improvement in clinical outcom ...
Nylon, the durable and elastic material, is like other plastics made from chemicals found in fossil fuels. Biodegradable plastics based on biomass-derived compounds are attracting attention as an ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果